New book on RNA Interference edited by Mouldy Sioud recently published
Mouldy Sioud from Department of Immunology at the Institute for Cancer Research is the editor of a new book published November 10th entitled "RNA Interference: Challenges and Therapeutic Opportunities". The book is included in the series "Methods in Molecular Biology, Vol. 1218" and provides readers with recent advances in siRNA design, delivery, targeting and methods to minimize siRNA's unwanted effects. Preclinical and clinical use of synthetic siRNAs, the roles of miRNAs in cancer and the promise of extracellular miRNAs for diagnosis are also covered in this meticulous collection, along with novel methods for identifying endogenous siRNAs and the annotation of small RNA transcriptomes.
These excellent chapters will assist researchers, clinicians, teachers and biotechnologists interested in the power of RNA-based therapies.
Written for the highly successful Methods in Molecular Biology series, chapters include the kind of detail and key implementation advice that ensures successful results in the laboratory.
Includes cutting-edge techniques in using RNA interference for therapeutic purposes
Provides step-by-step detail essential for reproducible results
Contains key notes and implementation advice from the experts
From major journals, first or last author from the Institute for Cancer Research
Chen Y, He L, Ianevski A, Ayuda-Durán P, Potdar S, Saarela J, Miettinen JJ, Kytölä S, Miettinen S, Manninen M, Heckman CA, Enserink JM, Wennerberg K, Aittokallio T(2023) Robust scoring of selective drug responses for patient-tailored therapy selection Nat Protoc(in press) DOI 10.1038/s41596-023-00903-x, PubMed 37996540
Al Outa A, Hicks S, Thambawita V, Andresen S, Enserink JM, Halvorsen P, Riegler MA, Knævelsrud H(2023) CELLULAR, A Cell Autophagy Imaging Dataset Sci Data, 10(1), 806 DOI 10.1038/s41597-023-02687-x, PubMed 37973836
García-Díaz N, Wei Q, Taskén K(2023) Small molecule inhibitors targeting regulatory T cells for cancer treatment Eur J Immunol, e2350448(in press) DOI 10.1002/eji.202350448, PubMed 37937687
Spasevska I, Sharma A, Steen CB, Josefsson SE, Blaker YN, Kolstad A, Rustad EH, Meyer S, Isaksen K, Chellappa S, Kushekhar K, Beiske K, Førsund MS, Spetalen S, Holte H, Østenstad B, Brodtkorb M, Kimby E, Olweus J, Taskén K, Newman AM, Lorenz S, Smeland EB, Alizadeh AA, Huse Ket al.(2023) Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma Blood Adv, 7(23), 7216-7230 DOI 10.1182/bloodadvances.2023010158, PubMed 37695745
Hindi N, Razak A, Rosembaum E, Jonczak E, Hamacher R, Rutkowski P, Bhadri VA, Skryd A, Brahmi M, Alshibany A, Jagodzinska-Mucha P, Bauer S, Connolly E, Gelderblom H, Boye K, Henon C, Bae S, Bogefors K, Vincenzi B, Martinez-Trufero J, Lopez-Martin JA, Redondo A, Valverde C, Blay JY, Moura DSet al.(2023) Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry ESMO Open, 8(6), 102045(in press) DOI 10.1016/j.esmoop.2023.102045, PubMed 38016251
Børø S, Thoresen S, Boge Brant S, Helland Å(2023) Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer Acta Oncol, 62(12), 1642-1648 DOI 10.1080/0284186X.2023.2264484, PubMed 37801361